• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗合成酶综合征疾病中血浆免疫球蛋白G的N-糖基化模式

N-glycosylation patterns of plasma immunoglobulin G in anti-synthetase syndrome disease.

作者信息

Zhao Jing, Li Yanhong, Ling Yingying, Wu Tong, Wu Yinlan, Tan Chunyu, Cheng Lu, Huang Deying, Liu Yi, Zhang Yong

机构信息

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Immunol. 2025 Jun 18;16:1538219. doi: 10.3389/fimmu.2025.1538219. eCollection 2025.

DOI:10.3389/fimmu.2025.1538219
PMID:40607430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12214897/
Abstract

INTRODUCTION

Anti-synthetase syndrome (ASS) is a subtype of idiopathic inflammatory myopathy (IIM) characterized by characteristic rash, myositis, and interstitial lung disease (ILD). The etiology of ASS is unknown, and patients have a poor quality of life and are prone to pulmonary infection. Recent studies have elucidated the potential role of abnormal glycosylation of immunoglobulin G (IgG) in the pathogenesis of autoimmune diseases. However, the pattern of patient-specific IgG N-glycosylation in ASS has not been fully elucidated.

METHODS

the GlycoQuant method was used to quantify the intact N-glycopeptides of IgG from 30 ASS patients and 30 healthy controls (HCs).

RESULTS AND DISCUSSION

Thirteen differentially expressed intact N-glycopeptides were identified (p<0.05). Notably, we observed increased fucosylation (p<0.0001) and decreased N-acetylneuraminic acid (p<0.05) in ASS patients. In addition, specific glycosylation patterns correlated with lung function parameters. Our study revealed the IgG glycosylation profile in ASS patients and provided a valuable reference for further investigation of its potential diagnostic and prognostic applications.

摘要

引言

抗合成酶综合征(ASS)是特发性炎性肌病(IIM)的一种亚型,其特征为典型皮疹、肌炎和间质性肺疾病(ILD)。ASS的病因尚不清楚,患者生活质量较差,且易发生肺部感染。最近的研究阐明了免疫球蛋白G(IgG)异常糖基化在自身免疫性疾病发病机制中的潜在作用。然而,ASS中患者特异性IgG N-糖基化模式尚未完全阐明。

方法

采用GlycoQuant方法对30例ASS患者和30例健康对照(HCs)的IgG完整N-糖肽进行定量分析。

结果与讨论

鉴定出13种差异表达的完整N-糖肽(p<0.05)。值得注意的是,我们观察到ASS患者岩藻糖基化增加(p<0.0001),N-乙酰神经氨酸减少(p<0.05)。此外,特定的糖基化模式与肺功能参数相关。我们的研究揭示了ASS患者的IgG糖基化谱,为进一步研究其潜在的诊断和预后应用提供了有价值的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/17c540715e6a/fimmu-16-1538219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/69275a86c715/fimmu-16-1538219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/8dfd6b0916f2/fimmu-16-1538219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/d44887df9b72/fimmu-16-1538219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/14b7580913c5/fimmu-16-1538219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/17c540715e6a/fimmu-16-1538219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/69275a86c715/fimmu-16-1538219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/8dfd6b0916f2/fimmu-16-1538219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/d44887df9b72/fimmu-16-1538219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/14b7580913c5/fimmu-16-1538219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ce/12214897/17c540715e6a/fimmu-16-1538219-g005.jpg

相似文献

1
N-glycosylation patterns of plasma immunoglobulin G in anti-synthetase syndrome disease.抗合成酶综合征疾病中血浆免疫球蛋白G的N-糖基化模式
Front Immunol. 2025 Jun 18;16:1538219. doi: 10.3389/fimmu.2025.1538219. eCollection 2025.
2
Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report.抗Ha抗体阳性抗合成酶综合征相关间质性肺疾病急性加重:一例报告
Front Immunol. 2025 Jun 12;16:1614777. doi: 10.3389/fimmu.2025.1614777. eCollection 2025.
3
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
4
Prevalence of Anti-Synthetase Syndrome in Patients of Interstitial Lung Disease with Connective Tissue Diseases and Autoimmune Features: A Cross-Sectional Study.间质性肺病合并结缔组织病及自身免疫特征患者中抗合成酶综合征的患病率:一项横断面研究
Mediterr J Rheumatol. 2025 Mar 31;36(1):107-115. doi: 10.31138/mjr.180324.dtc. eCollection 2025 Mar.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
7
Integration of clinical and serological biomarkers in a nomogram for predicting interstitial lung disease in idiopathic inflammatory myopathies.临床和血清生物标志物在预测特发性炎性肌病间质性肺病的列线图中的整合。
BMC Rheumatol. 2025 Jul 1;9(1):73. doi: 10.1186/s41927-025-00534-7.
8
Characterizing local antibody responses in the muscle of inclusion body myositis patients.表征包涵体肌炎患者肌肉中的局部抗体反应。
J Autoimmun. 2025 Jun;154:103437. doi: 10.1016/j.jaut.2025.103437. Epub 2025 May 26.
9
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
10
Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.利妥昔单抗治疗后迟发性中性粒细胞减少症:病例系列及文献综述
Medicine (Baltimore). 2010 Sep;89(5):308-318. doi: 10.1097/MD.0b013e3181f2caef.

本文引用的文献

1
Deciphering N-Glycosylation Dynamics of Serum Monoclonal Immunoglobulins in Multiple Myeloma via EThcD-sceHCD-MS/MS.通过电子转移解离-单克隆抗体重链特异性高分辨质谱法解析多发性骨髓瘤患者血清单克隆免疫球蛋白的N-糖基化动力学
J Proteome Res. 2025 May 2;24(5):2553-2563. doi: 10.1021/acs.jproteome.5c00253. Epub 2025 Apr 9.
2
Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis.定量位点特异性N-糖基化分析揭示用于胰腺癌诊断的IgG糖基特征。
Clin Proteomics. 2024 Dec 30;21(1):68. doi: 10.1186/s12014-024-09522-4.
3
A Novel Integrated Pipeline for Site-Specific Quantification of N-glycosylation.
一种用于N-糖基化位点特异性定量的新型集成流程
Phenomics. 2024 Apr 10;4(3):213-226. doi: 10.1007/s43657-023-00150-w. eCollection 2024 Jun.
4
Clinical glycoproteomics: methods and diseases.临床糖蛋白质组学:方法与疾病
MedComm (2020). 2024 Oct 4;5(10):e760. doi: 10.1002/mco2.760. eCollection 2024 Oct.
5
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases.抗体糖基化在自身免疫和同种免疫性肾脏疾病中的作用。
Nat Rev Nephrol. 2024 Oct;20(10):672-689. doi: 10.1038/s41581-024-00850-0. Epub 2024 Jul 3.
6
Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.抗合成酶综合征患者抗-Jo-1 抗体水平的临床和预后相关性。
Respir Res. 2024 May 29;25(1):222. doi: 10.1186/s12931-024-02851-w.
7
Editorial: New methods, techniques and applications in clinical glycoproteomics.社论:临床糖蛋白质组学中的新方法、技术及应用
Front Mol Biosci. 2023 Mar 3;10:1170818. doi: 10.3389/fmolb.2023.1170818. eCollection 2023.
8
Glycobiology of rheumatic diseases.风湿性疾病的糖生物学。
Nat Rev Rheumatol. 2023 Jan;19(1):28-43. doi: 10.1038/s41584-022-00867-4. Epub 2022 Nov 23.
9
Site-specific N-glycosylation characterization of micro monoclonal immunoglobulins based on EThcD-sceHCD-MS/MS.基于 EThcD-sceHCD-MS/MS 的微单克隆免疫球蛋白的位点特异性 N-糖基化分析。
Front Immunol. 2022 Sep 15;13:1013990. doi: 10.3389/fimmu.2022.1013990. eCollection 2022.
10
N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization.单克隆抗体治疗药物的 N-糖基化:意义和特征的全面综述。
Anal Chim Acta. 2022 May 29;1209:339828. doi: 10.1016/j.aca.2022.339828. Epub 2022 Apr 13.